Our popular course is next running 14th - 15th April in Cambridge, UK.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationPrice: USD ($) 12.00
Please note: payment is required before the ebooklet is sent via email. However if you need earlier access please contact publications@therqa.com.
VAT on Electronic Books is chargeable in the UK and EU. Please see the 'Booklet Terms and Conditions' for further details.
This handbook was developed for Quality Assurance (QA) professionals to support reviewing, advising and overseeing non-interventional studies (NIS) for medicinal products, but can be of use to anyone engaged in NIS for medicinal products.
The handbook offers practical considerations and insights to help the reader navigate existing guidance and apply a risk-proportionate approach to QA oversight of the design and conduct of NIS. The content draws on current industry standards, regulatory frameworks and the authors’ combined experience in this area. The regulations and guidance cited were accurate at the time of writing; readers should verify the latest requirements.
Robust QA oversight of NIS should be grounded on key concepts and principles, with careful attention to the complexity of relevant regulations. Given the diversity and nuances of different types of NIS, the degree of oversight should be tailored accordingly and remain proportionate to the associated risks.
The focus of this handbook is non-interventional studies of medicinal drug products (synonymous with drug product). Though some principles are the same, NIS related to medical devices are not discussed and are out of scope as the regulatory requirements differ significantly from medicinal drug products.
Members of the Research Quality Association (RQA) Pharmacovigilance Committee, Japanese Society of Quality Assurance (JQSA) and the RQA Non-Interventional Study Special Interest Group
2026